SIT INVESTMENT ASSOCIATES INC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 144 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIT INVESTMENT ASSOCIATES INC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$155,000
-4.3%
26,7250.0%0.00%
+33.3%
Q1 2016$162,000
-33.6%
26,7250.0%0.00%
-40.0%
Q4 2015$244,000
+61.6%
26,7250.0%0.01%
+66.7%
Q3 2015$151,000
-49.0%
26,7250.0%0.00%
-40.0%
Q2 2015$296,000
-29.4%
26,7250.0%0.01%
-28.6%
Q1 2015$419,000
-38.1%
26,725
-40.0%
0.01%
-36.4%
Q4 2014$677,000
+30.7%
44,525
-7.2%
0.01%
+22.2%
Q3 2014$518,000
-53.4%
48,005
-34.1%
0.01%
-52.6%
Q2 2014$1,112,000
+28.0%
72,805
+51.5%
0.02%
+26.7%
Q1 2014$869,00048,0550.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders